Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Mbio|June 22, 2023
SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replicationChristina A Higgins, Benjamin E Nilsson-Payant, Boris Bonaventure, et al.
Journal of the American Chemical Society|December 7, 2018
A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site IdentificationChristopher M Browne, Baishan Jiang, Scott B Ficarro, et al.
Nature Biotechnology|July 29, 2026
An AI-enabled structural atlas decodes kinase specificity across the human proteomeDavid R Vanderwall, Edward L Huttlin, Julian Mintseris, et al.
Nature Communications|May 22, 2025
Comprehensive evaluation of phosphoproteomic-based kinase activity inferenceSophia Müller-Dott, Eric J Jaehnig, Khoi Pham Munchic, et al.
Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.
Nature Chemical Biology|February 24, 2023
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitorNarek Darabedian, Wenzhi Ji, Mengyang Fan, et al.
Cancer Discovery|November 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive TumorigenesisShuang Tang, Qian Zhou, Johann S Bergholz, et al.
Developmental Cell|July 21, 2026
Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesisAdrien Grimont, David J Falvo, Whitney J Sisso, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesisAdrien Grimont, David J Falvo, Whitney J Sisso, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Pageof 29